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A B ST R AC T  
 
Aim: To evaluate the role of the diameter of the optic nerve sheath (ONSD) in the differential 
diagnosis of the central and peripheral vertigo in patients, who had applied with the complaints of 
vertigo. 
Method:  Our study had a prospective design and 113 vertigo patients were included in the study. 
The demographic characteristics, vital signs, symptoms accompanying vertigo and findings of the 
imaging examinations were evaluated. 
Results: The median age of our patients was 43 years (IQR: 17) and 44.2 % of them were males. 19.5 
% of the patients were diagnosed with central and 80.5 % with peripheral vertigo. In our study, the 
median ONSD was 4.88 mm (IQR=0.86) in patients with central vertigo and 4.65 mm (IQR=0.20) in 
patients with peripheral vertigo. The median value of ONSD in patients with central vertigo was 
significantly higher (p=0.030). In our study, the area under the curve was 0.654 (95 % CI=0.498-
0.810) and the sensitivity and specificity for the cut-off value of 4.65 mm were 68.2 % and 61.5 % 
respectively. 
Conclusion: We determined that ONSD was larger in patients with central vertigo. Further studies 
with larger subject size are needed on this topic.  
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Introduction 
Vertigo is in the top 10 among the admissions 
to the emergency units. Vertigo is a dizzying 
sensation of being in tilting or spinning 
surroundings. The rate of the lifetime and 
yearly prevalence of vertigo are 7.4 % and 4.9 
% respectively [1]. 
40-60 % of all vertigo cases are caused by the 
peripheral vestibular dysfunction, 10-20 % by 
the central causes, 1-2 % by the medication, and 
15 % by the psychiatric disorders. 10 % of the 
cases are caused by unknown pathological 
conditions [2,3]. 
It was determined that one-third of the patients, 
who were discharged from the emergency units 
with the diagnosis of peripheral vertigo, had 
posterior ischemia. The rate of the morbidity 
and mortality increase in patients with the 
wrong diagnosis due to the lack of an 
appropriate treatment [4]. It has been 
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demonstrated that the brain perfusion is 
impaired and the intracranial pressure is 
increased in several cerebrovascular disorders, 
which may cause vertigo [4]. 
Hayreh had shown in 1978 that the optic nerve 
sheath diameter (ONSD) was dilated in patients 
with increased intracranial pressure (ICP). 
Following this study, the physicians started to 
focus on the determination of the ICP with non-
invasive methods [5]. In the recent studies, the 
importance of ONSD in the diagnosis of ICP 
was evaluated in the disorders (e.g. cranial 
trauma, stroke, intracranial mass lesion, 
infection etc.) accompanied by the increased 
ICP and encouraging results were obtained [6-
9]. There are no publications in the literature 
regarding the ONSD in the differential 
diagnosis of the central and peripheral vertigo. 
In our study, our objective was to evaluate the 
role of ONSD in the differential diagnosis of 
central and peripheral vertigo in patients, who 
applied with the complaint of vertigo. 
 
Materials and Methods 
Following the approval of the Ethics 
Committee of the Medical Faculty at Bolu 
Abant Izzet Baysal University (Date: 
08/02/2018; Decision number: 2018/13), 113 
volunteered patients, who had applied to our 
emergency clinic between 01.02.2018-
31.07.2018 and had isolated vertigo, were 
investigated in a prospective design. All 
procedures performed in studies involving 
human participants were in accordance with the 
ethical standards of the Institutional Research 
Ethics Committee and with the 1964 Helsinki 
Declaration and its later amendments or 
comparable ethical standards. 
Informed consent was obtained from all 
participants prior to being included in the study. 
We established a standardized form for data 
collection. The demographic characteristics 
(age, gender), vital signs (systolic and diastolic 
blood pressure and heart rate at admission) and 
symptoms of the patients, who were enrolled 
into the study, were recorded. In the patients 
with central vertigo, cranial tomography (CT) 
was performed and we also examined the 
images of the diffusion magnetic resonance 
imaging (DW-MRI) if we did not observe any 
pathological finding in CT. In our study, 




















A trained emergency medicine specialist 
carried out 7.5 MHz linear probe measurement, 
after the application of a thin layer of a gel on 
both eyes of the patients, who were in the 
supine position. The diameter of the optic nerve 
sheath was evaluated with transverse and 
sagittal measurements at the 3 mm beyond the 
posterior of the eye globe. The mean value of 
the ONSD was calculated as the mean value of 
the transverse and sagittal ONSD 
measurements. All images were confirmed by a 
blinded emergency medicine specialist and the 
groups were compared. 
Table 1. Exclusion criteria. 
1 Not give his/her informed consent 
2 Not want to share medical information 
due to any reason 
3 Previous cerebrovascular event (CVE) 
or trans-ischemic attack (TIA) 
4 Below the age of 18 years 
5 Hypertensive encephalopathy 
6 Vascular dementia 
7 Liver insufficiency 
8 Chronic kidney failure 
9 Pregnant or breastfeeding 
10 Trauma 
11 Optic nerve trauma 
12 Optic neuritis 
13 Optic nerve arachnoid cyst and mass 
lesion in the orbita/cavernous sinus 
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Age (year), Median 
(IQR) 
 60.5 (35) 43 (15) 0.001* 
Gender, n (%) Male 11 (50) 39 (42.9) 
0.545** 
Female 11 (50) 52 (57.1) 
Duration (hours), 
Median (IQR) 
 16 (19) 4 (6) <0.001* 
Vertigo attack in the medical history, n (%) 
 
      3 (13.6) 19 (20.6) 0.559*** 
Symptoms, n (%) Headache 8 (36.4) 14 (15.4) 0.036*** 
Sudden Onset 11 (50.0) 77 (84.6) 0.001*** 
Nausea/vomiting 13 (59.1) 62 (68.1) 0.421** 
Hearing impairment 4 (18.2) 30 (33.0) 0.175** 
The feeling of fullness in the 
ear 
0 25 (27.5) 0.003** 
Tinnitus 2 (9.1) 38 (41.8) 0.004** 
Balance disorder 10 (45.5) 21 (23.1) 0.035** 
Nystagmus, n (%) None 7 (31.8) 41 (45.1) 
<0.001* Horizontal 6 (27.3) 50 (54.9) 
Vertical/rotatory 9 (40.9)  
Imaging, n (%) Restriction in D-MRI 8 (36.4) 
 
 
Cerebellar infarction in CT 5 (22.7) 
Lacunar infarction in CT 2 (9.1) 
Bleeding in CT 1 (4.5) 
No special finding in CT 
and MRI 
6 (27.3) 
Vital Signs, Median 
(IQR) 
Systolic blood pressure 
(mmHg) 
134.5 (19) 133 (38) 0.488* 
Diastolic blood pressure 
(mmHg) 
81 (12) 81 (16) 0.881* 
Pulse (beats/min) 82.5 (17) 75 (22) 0.189* 
Comorbidity, n (%) Comorbidity 13 (59.1) 33 (36.3) 0.050** 
Hypertension 6 (27.3) 17 (18.7) 0.384*** 
Diabetes mellitus 3 (13.6) 14 (15.4) 0.837*** 
Previous 
CerebroVascularAccident 3 (13.6) 8 (8.8) 
 
0.491** 
Other 4 (18.2) 4 (4.4) 0.045*** 
* Mann-Whitney U, ** Pearson's Chi-square test, *** Fisher's Exact test, n: number of patients, CT: cranial 
tomography, MRI: magnetic resonance imaging, D-MRI: diffusion magnetic resonance imaging. 
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The data were uploaded to a computer and 
analyzed with SPSS (Statistical Package for 
Social Sciences) Windows v22.0 software 
package. The descriptive statistics were 
expressed in numbers (n) and in percentages. 
The distribution of the continuous data was 
analyzed with the Kolmogorov-Smirnov test. 
Median and interquartile range (IQR) were used 
for the evaluation of the quantitative data. 
Mann-Whitney U test was used for the 
comparison of the continuous data and Chi-
square test and Fisher's Exact test were used for 
the comparison of the categorical data. ROC 
curves were drawn in order to test the role of 
ONSD in the differential diagnosis of central 
and peripheral vertigo. The sensitivity and 
specificity were calculated for central vertigo. 
The results were evaluated in a confidence 




The median age of our patients was 43 years 
(IQR: 17) and 44.2 % of them were males. 22 
patients (19.5%) had central and 91 patients 
(80.5%) peripheral vertigo. The mean age of the 
patients with central vertigo was higher and the 
duration of vertigo was longer compared to the 
patients with peripheral vertigo (p <0.05).  
The frequency of vertigo attacks was 
comparable between the genders and the groups 
(p>0.05). Although headache and balance 
problems were more common in the central 
vertigo group, sudden onset, feeling of fullness 
in the ear and tinnitus were the prominent 
characteristics of peripheral vertigo (p<0.05). 
57.5% of the patients had nystagmus and 
vertical/rotatory nystagmus was significantly 
more common in the central vertigo group 
(p<0.05). Regarding the imaging examination 
of the central vertigo patients, the restriction 
was most commonly encountered in the D-MRI 
examination (36.4 %). There was no difference 
between the groups in terms of vital parameters 
and comorbidity (p>0.05) (Table 2). 
In our study, the median ONSD was 4.88 mm 
(IQR=0.86) in patients with central vertigo and 
4.65 mm (IQR=0.20) in patients with peripheral 
vertigo. The median of ONSD in patients with 
central vertigo was significantly higher 



















ROC curves were drawn in order to test the role 
of ONSD in the differential diagnosis of central 
and peripheral vertigo. The area under the curve 
was 0.654 (95 % CI=0.498-0.810) and the 
sensitivity and specificity for the cut-off value 
of 4.65 mm were 68.2 % and 61.5 % 
respectively (Figure 2). 
 
Discussion 
We found no study in the literature focused on 
the ONSD measurements for the differential 
diagnosis of the central and peripheral vertigo. 
Nevertheless, it has been demonstrated that 
ONSD was increased in strokes and traumatic  
 
Figure 1. The comparison of the groups for 
ONSD. 
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hemorrhages [6, 10-12]. The impairment of the 
cerebral blood perfusion due to the hypoxia, 
bleeding and edema and the increase of ICP due 
to the impairment in the CSF circulation may 
lead to the dilatation of ONSD [13,14]. In our 
study, the ONSD was significantly larger in the 
patients with central vertigo. We believe that 
this finding depended on the increase of ICP 
due to the emergence of edema and the 
deterioration of the CSF circulation. 
Batur reported in his thesis study that the 
sensitivity and specificity of the US in ICP was 
95.7 % and 100 % respectively [15]. In patients 
with ischemia, the sensitivity and specificity 
were 76-80 % and 84-86 % respectively [6,16]. 
In the patients with intracranial bleeding, the 
sensitivity and specificity were 74-100 % and 
72.7-100 % respectively [17,18]. In our study, 
regarding central vertigo, for a cut-off value of 
4.65 mm, the sensitivity and specificity were 
68.2 % and 61.5 % respectively. The specificity 
and sensitivity levels were lower than the 
previous studies and it might be related that the 
present disorders like ischemia/bleeding did not 
severely affect the CSF circulation. In addition, 
certain disorders, which did not increase ICP 
(vestibular migraine, multiple sclerosis, 
epileptic migraine etc.) but cause central 
vertigo, might decrease the sensitivity. The 
misdiagnosis of some central vertigo as 
peripheral vertigo might be the most important 
reason for the low level of the specificity.  
The optic nerve is considered as an extension of 
the brain tissue, as it originates directly from the 
brain tissue, is protected by the same sheaths 
(dura mater, arachnoid and pia mater) as the 
brain and has Schwann's sheath in its structure 
[19]. ICP, which is common in the intracranial 
events, increases the mortality and morbidity in 
addition to the secondary injuries [17,20]. Xue 
et al. suggested that 17 % of all vertigo cases 
depended on central causes [3]. However, Hain 
and Yacovino stated that the rate of the central 
vertigo is below 5 % [21]. Branch and Barton 
reported that the rate of central vertigo was 10 
% and added that the rate of central vertigo 
might increase up to 20 % with aging [2]. In our 
study, the rate of central vertigo was 19.5 %, 
which was higher than the reported rates in the 
literature. The relatively older patient 
population of our study may be the main reason 
for this result.  
Tinetti et al. [22] and Lin et al. [23] reported 
that the rate of dizziness might be increased up 
to 38 % in the elderly patients. Gönüllü and 
Aygün reported in their study that vertigo was 
more common in women and central vertigo 
was more common in elderly patients [24]. 
They stated that this might be a result of the 
impairment of the nerve structures, of the 
increase in depression, and cardiovascular 
disease rates and of the side effects of the 
medication. It has also been reported that 
elderly patients are more likely to apply with 
central vertigo [2]. In our study, we determined 
that central vertigo was more common in older 
Figure 2. Diagnostic ROC for ONSD. 
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male patients. This finding might be related to 
the comorbidities, which were increased with 
aging; to the impaired metabolism and to the 
decline of the ischemic events in women due to 
the estrogen. We also believe that the previous 
strokes have a special place in the etiology of 
central vertigo. 
Nystagmus depends on the continuous stimuli 
to the optic nerve, which emerge to preserve the 
accommodation with the help of the chemical 
and electrical mediators, which were released in 
the brain as a response to the new condition 
caused by the dizziness [18]. Studies have 
demonstrated that sudden onset, horizontal 
nystagmus and hearing symptoms are 
prominent in peripheral vertigo and slow onset, 
vertical/rotatory nystagmus, headache and 
balance disorders are at the forefront in central 
vertigo [25,26]. In our study, we determined 
that slow onset, headache, balance problems 
and vertical/rotatory nystagmus were more 
common in the patients with central vertigo and 
sudden onset, feeling of fullness in the ear, and 
tinnitus and horizontal nystagmus were more 
common in patients with peripheral vertigo. We 
believe that in central vertigo, central events 
(cerebellar infarction, vestibular migraine, 
intracranial hemorrhage etc.) cause headache 
and balance problems due to the emergence of 
the irritation and the impact on the balance 
system. On the other hand, symptoms related to 
the ear are more common in peripheral vertigo, 
as it is mainly caused by the vestibular 
dysfunction. It may be suggested that the 
symptoms progress slowly depending on the 
penumbra, which enlarges with time in the 
ischemic events.  
Xue et al. investigated 2481 patients with 
central vertigo and reported that central vertigo 
emerged due to the cerebrovascular disorders 
(59 %), vestibular migraine (21.6 %), vestibular 
paroxysmia (13.5 %), degenerative disorders (3 
%), sensorineural hearing loss (2 %) and 
multiple sclerosis/optic neuromyelitis (0.9 %) 
[3]. Riberio et al. stated that besides ischemia 
and bleeding, central vertigo was also caused by 
certain conditions like tumors, infections and 
anatomical disorders [27]. In our study, the 
most common finding was infarction and we 
did not observe any pathological finding in 27.3 
% of the patients. We believe that the most 
common cause of the central vertigo is 
ischemia, which was also a finding in our study. 
In addition, we also believe that 27.3 % of the 
patients remained undiagnosed, as some 
ischemia and small bleeding areas could not be 
detected with the imaging methods and other 
imaging methods were needed for certain 
diagnosis except CT and DW-MRI.  
Berkiten et al. reported in their study that high 
blood pressure might provoke vertigo [25]. In 
some studies, it was demonstrated that in 
certain comorbidities, in which stroke was 
common, the rate of the stroke-related vertigo 
was increased [13,14,28].  It is also known that 
some drugs trigger vertigo [2,3]. In our study, 
we did not detect any correlation between the 
comorbidities and the vital parameters. We 
believe that this finding depended on the fact 
that the factors related to the comorbidities 
were found in both central and peripheral 
vertigo. We also believe that it was increased 
due to itself in central vertigo and due to the 
elevated stress in peripheral vertigo and 
therefore there was no difference between the 
groups.  
The most important limitation of our study is a 
single center study, and it was carried out on a 
small population. Our results must be supported 
by multi-center studies. 
Conclusion 
We conclude that the ONSD measurement may 
be used to support the differential diagnosis of 
the central and peripheral vertigo. Further 
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studies with larger subject size are needed on 
this topic. 
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